See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Tullis Health Investors is a commercial-stage healthcare investment manager that partners with high-growth, scalable healthcare companies. The firm focuses exclusively on healthcare investments across medical devices, healthcare services and technology, specialty pharmaceuticals, and biotechnology sectors. Founded in 1986, Tullis manages a family of funds focused geographically on North America. The firm emphasizes repeatable, scalable commercial healthcare investing with a strategy that minimizes exposure to regulatory and technology development risks. Tullis seeks companies with novel and differentiated healthcare technologies that address large addressable markets, providing growth capital and active portfolio support including deal sourcing, clinical and regulatory expertise, board-level engagement, and commercialization support to scale companies.
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| electroCore, Inc. | Growth | — | — |
| TriSalus Life Sciences | Series C | — | 2015-11 |
| Channel Medsystems | Growth | — | — |
| Exagen, Inc. | Growth | — | — |
| DocMatter | Growth | — | — |
| Alphatec Spine, Inc. | Growth | — | — |
| Synageva BioPharma Corp. | Growth | — | — |
| Genoptix, Inc. | Growth | — | — |
| Adams Respiratory Therapeutics, Inc. | Growth | — | — |
| Atritech, Inc. | Growth | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| KMG Capital Partners | 3 |
| Greycroft | 1 |
Fit check
Is Tullis Health Investors a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit